List of Suboxone drug patents

Suboxone is owned by Indivior Inc.

Suboxone contains Buprenorphine Hydrochloride; Naloxone Hydrochloride.

Suboxone has a total of 8 drug patents out of which 3 drug patents have expired.

Expired drug patents of Suboxone are:

  • US9855221
  • US9931305
  • US10285910

Suboxone was authorised for market use on 30 August, 2010.

Suboxone is available in film;buccal, sublingual dosage forms.

Suboxone can be used as this drug is administered by sublingual route to humans for maintenance treatment of opioid dependence, treatment of opioid dependence/sublingual or buccal application, treating opioid use disorder.

The generics of Suboxone are possible to be released after 26 March, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9855221 INDIVIOR INC Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Feb, 2022

(11 months ago)

US9931305 INDIVIOR INC Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Feb, 2022

(11 months ago)

US10285910 INDIVIOR INC Sublingual and buccal film compositions
Oct, 2022

(3 months ago)

US8017150 INDIVIOR INC Polyethylene oxide-based films and drug delivery systems made therefrom
Feb, 2023

(13 days from now)

US8603514 INDIVIOR INC Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Apr, 2024

(1 year, 2 months from now)

US11135216 INDIVIOR INC Sublingual and buccal film compositions
Aug, 2029

(6 years from now)

US9687454 INDIVIOR INC Sublingual and buccal film compositions
Aug, 2029

(6 years from now)

US8475832 INDIVIOR INC Sublingual and buccal film compositions
Mar, 2030

(7 years from now)

Drugs and Companies using BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 30 August, 2010

Treatment: Treatment of opioid dependence/sublingual or buccal application; Treating opioid use disorder; This drug is administered by sublingual route to humans for maintenance treatment of opioid dependence

Dosage: FILM;BUCCAL, SUBLINGUAL

How can I launch a generic of SUBOXONE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in